This April, let’s celebrate our community and continue working towards increasing global diagnosis rates, so we can move one step closer to our shared vision of Treatment for All.
Accurate diagnosis is the gateway to care for people living with bleeding disorders. Yet in many parts of the world, barriers continue to delay or prevent proper diagnosis—leading to unacceptably low diagnosis rates. The challenge is even greater for people with von Willebrand disease, rare bleeding disorders, and for women and girls with bleeding disorders. On April 17, I call on the global community to unite in advocating for stronger diagnostic capabilities everywhere—because without diagnosis, there is no treatment, and without treatment, there is no progress.
—Cesar Garrido, President, WFH
How to get involved
There are many ways you can help raise awareness about diagnosis rates for people bleeding disorders in your community and globally. While the 2026 theme serves as a guide, feel free to tailor it to fit the needs of your region and organization. We will soon be sharing a variety of engagement options on our World Hemophilia Day webpage and the WFH News page. Additionally, make sure to follow the WFH social media channels (Facebook, X (Twitter), LinkedIn, and Instagram) for the latest World Hemophilia Day updates.
Resources
You can find downloadable posters, banners, logos, and social media visuals on the World Hemophilia Day webpage. In the coming months, we’ll also be making an Advocacy Toolkit, a government letter template, and other campaign materials available, so be sure to check back often!
Learn more about World Hemophilia Day here.
The WFH would like to thank our 2025 World Hemophilia Day sponsors for their continued support: Bayer, BioMarin Pharmaceutical Inc., Biotest, CSL Behring, F. Hoffman-La Roche Ltd., GC Pharma, Grifols, Kedrion, LFB S.A, Novo Nordisk, Octapharma, Pfizer, Sanofi, Sobi, and Takeda.